IVRAFERAV

Antiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, antivirals; Vaccine preparations; Vaccines; Viral vaccines